Global Leuprolide Acetate Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Leuprolide Acetate Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Leuprolide acetate is a synthetic nonapeptide that is a potent gonadotropin-releasing hormone receptor (GnRHR) agonist used for diverse clinical applications, including the treatment of prostate cancer, endometriosis, uterine fibroids, central precocious puberty and in vitro fertilization techniques. Leuprolide acetate is given by injection into a muscle or under the skin.
Leuprolide Acetate report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Leuprolide Acetate market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Prostate Cancer and Precocious are the major drivers for the industry.
Leuprorelin was approved for medical use in the United States in 1985. It is on the World Health Organization's List of Essential Medicines, the most effective and safe medicines needed in a health system. In the United Kingdom a monthly dose costs the NHS about 75.24 pounds. In the United States the equivalent dose has a wholesale cost of 1,011.93 USD.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Leuprolide Acetate market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Mode of Administration, Application and Regions Listed in the Report
Tolmar Pharmaceuticals
Varian Pharmed
Avenit
Takeda Pharmaceutical
Sun Pharmaceutical Industries
Livzon Pharmaceutical
Beijing Biote Pharmaceutical
Soho-YImIng
AbbVie
Sanofi
Astellas Pharma
Abbott
Merck
Pfizer
Segment by Mode of Administration
Intramuscular
Subcutaneous
Prostate Cancer
Precocious
Uterine Fibroid
Others
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Leuprolide Acetate market further
Chapter 1Product Definition, Product Mode of Administrations, Volume and Revenue analysis of Each Mode of Administration in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Leuprolide Acetate, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Leuprolide Acetate industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Leuprolide Acetate in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Leuprolide Acetate introduction, etc. Leuprolide Acetate Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Leuprolide Acetate market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Leuprolide Acetate report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Leuprolide Acetate market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Prostate Cancer and Precocious are the major drivers for the industry.
Leuprorelin was approved for medical use in the United States in 1985. It is on the World Health Organization's List of Essential Medicines, the most effective and safe medicines needed in a health system. In the United Kingdom a monthly dose costs the NHS about 75.24 pounds. In the United States the equivalent dose has a wholesale cost of 1,011.93 USD.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Leuprolide Acetate market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Mode of Administration, Application and Regions Listed in the Report
By Company
Tolmar Pharmaceuticals
Varian Pharmed
Avenit
Takeda Pharmaceutical
Sun Pharmaceutical Industries
Livzon Pharmaceutical
Beijing Biote Pharmaceutical
Soho-YImIng
AbbVie
Sanofi
Astellas Pharma
Abbott
Merck
Pfizer
Segment by Mode of Administration
Intramuscular
Subcutaneous
Segment by Application
Prostate Cancer
Precocious
Uterine Fibroid
Others
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Leuprolide Acetate market further
Chapter 1Product Definition, Product Mode of Administrations, Volume and Revenue analysis of Each Mode of Administration in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Leuprolide Acetate, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Leuprolide Acetate industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Leuprolide Acetate in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Leuprolide Acetate introduction, etc. Leuprolide Acetate Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Leuprolide Acetate market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.